These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 953866)

  • 1. Effect of (Sar1, Ala8)-angiotensin II and hypophysectomy on the intestinal resistance vessels and blood pressure following furosemide-induced volume depletion.
    McNeill JR; Wilcox WC; Regnault R
    Can J Physiol Pharmacol; 1976 Jun; 54(3):373-80. PubMed ID: 953866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal vasoconstriction following diuretic-induced volume depletion: role of angiotensin and vasopressin.
    McNeill JR
    Can J Physiol Pharmacol; 1974 Aug; 52(4):829-39. PubMed ID: 4371933
    [No Abstract]   [Full Text] [Related]  

  • 3. Vasopressin and angiotensin: reciprocal mechanisms controlling mesenteric conductance.
    McNeill JR; Wilcox WC; Pang CC
    Am J Physiol; 1977 Mar; 232(3):H260-6. PubMed ID: 842681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypophysectomy and saralasin on mesenteric vasoconstrictor response to vasopressin.
    Pang CC; Wilcox WC; McNeill JR
    Am J Physiol; 1979 Feb; 236(2):H200-5. PubMed ID: 420302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pentobarbital anesthesia and surgery on the control of arterial pressure and mesenteric resistance in cats: role of vasopressin and angiotensin.
    McNeill JR; Pang CC
    Can J Physiol Pharmacol; 1982 Mar; 60(3):363-8. PubMed ID: 7074422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal vasoconstriction after hemorrhage: roles of vasopressin and angiotensin.
    McNeill JR; Stark RD; Greenway CV
    Am J Physiol; 1970 Nov; 219(5):1342-7. PubMed ID: 4319646
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of adrenal arterial infusion of saralasin (P113) on aldosterone secretion.
    Blair-West JR; Coghlan JP; Denton DA; Niall HD; Scoggins BA; Tregear GW
    Prog Biochem Pharmacol; 1976; 12():53-62. PubMed ID: 1019170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist and antagonist effects of Sar1-ala8--angiotensin II in salt-loaded and salt-depleted normal man.
    MacGregor GA; Dawes PM
    Br J Clin Pharmacol; 1976 Jun; 3(3):483-7. PubMed ID: 973974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redistribution of regional blood flow after administration of saralasin in salt-depleted dogs.
    Liang CS; Gavras H; Brunner HR
    Clin Sci Mol Med Suppl; 1978 Dec; 4():243s-246s. PubMed ID: 282061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies of the humoral and arterial pressure responses to Sar1-Ala8-, Sar1-Ile8 and Sar1-Thr8-angiotensin II in the trained unanaesthetized dog.
    Bravo EL; Khosla MC; Bumpus FM
    Prog Biochem Pharmacol; 1976; 12():33-40. PubMed ID: 1019168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of angiotensin II receptor blockade by [Sar1-Ala8]angiotensin II in hemorrhagic shock.
    Trachte GJ; Lefer AM
    Am J Physiol; 1979 Feb; 236(2):H280-5. PubMed ID: 311160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of volume depletion, antidiuretic hormone and angiotensin II in the furosemide-induced decrease in mesenteric conductance in the dog.
    Schmitt SL; Taylor K; Schmidt R; Van Orden D; Williamson HE
    J Pharmacol Exp Ther; 1981 Nov; 219(2):407-14. PubMed ID: 7026766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo effects of angiotensin antagonists on plasma aldosterone in the dog.
    Beckerhoff R; Uhlschmid G; Furrer J; Nussberger J; Schmied UR; Vetter WJ; Siegenthaler W
    Eur J Pharmacol; 1975 Dec; 34(2):363-7. PubMed ID: 1234555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of Sar1-Ala8-angiotensin II in patients with renovascular hypertension.
    Fagard R; Amery A; Ljnen P; Reybrouck T; Billiet L
    Prog Biochem Pharmacol; 1976; 12():242-9. PubMed ID: 1019167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pressor response to 1-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects.
    Anderson GH; Streeten DH; Dalakos TG
    Circ Res; 1977 Mar; 40(3):243-50. PubMed ID: 837471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of infusions of catecholamines, angiotensin, vasopressin and histamine on hepatic blood volume in the anaesthetized cat.
    Greenway CV; Lautt WW
    Br J Pharmacol; 1972 Feb; 44(2):177-84. PubMed ID: 4358409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of prolactin secretion from rat pituitary by luteinizing hormone-releasing hormone: evidence against mediation by angiotensin II acting through a (Sar1-Ala8)-angiotensin II-sensitive receptor.
    Robberecht W; Andries M; Denef C
    Neuroendocrinology; 1992 Aug; 56(2):185-94. PubMed ID: 1407372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of an angiotensin antagonist, Sar1-Ala8-angiotensin II on physiological thirst.
    Abraham SF; Denton DA; McKinley MJ; Weisinger RS
    Pharmacol Biochem Behav; 1976 Mar; 4(3):243-7. PubMed ID: 935196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the specific angiotensin antagonist (Sar1) (Ala8) angiotensin II on blood pressure and the renin-angiotensin system in the conscious pregnant ewe and fetus.
    Broughton Pipkin F; O'Brien PM
    Am J Obstet Gynecol; 1978 Sep; 132(1):7-15. PubMed ID: 696788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.